The wound care management market comprises of dressings, equipment and other aids to prevent and treat wounds and quicken or promote wound healing. Traditional wound management involves the use of dressings which cover and protect the wound from infection. GlobalData uses proprietary data and analytics to provide a comprehensive report on the traditional wound management devices market, including market shares of different players within the US. Buy the latest report here.
Smarter leaders trust GlobalData
In 2022, GlobalData’s Market Model methodology determined that the leading player in the traditional wound management market in the US was Cardinal Health followed by Johnson & Johnson, Molnlycke Health Care, Medline Industries, B. Braun Melsungen, Smith & Nephew, Lohmann & Rauscher, Paul Hartmann, BSN medical and Datt Mediproducts.
Traditional wound dressings are dry and do not provide a moist wound environment. They are used as primary or secondary dressings or from composites of several dressings with each performing a specific function. They serve as inert barriers to the wound. This segment includes gauzes, sponges, bandages, gauze sponges, and abdominal pads.
Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the traditional wound management devices market within the US was expected to be over $1900m in 2022.
For the latest complete market share analysis of traditional wound management device market in the US, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
